CFO services for healthcare software companies.
Software sold into healthcare carries two sets of rules: the metrics every SaaS investor expects, and the sales cycles, compliance costs, and implementation realities of a healthcare buyer. We bring finance leadership that has run both — inside software companies and inside the provider organizations they sell to.
The finance problems that define this segment.
Implementation revenue is mixed with subscription revenue.
Onboarding, data migration, and training fees recognized alongside recurring fees inflate "ARR" and distort gross margin; investors separate them, and so should the books.
Sales cycles run six to eighteen months.
Health-system and large-group procurement, security review, legal, and committee approval stretch the pipeline; forecasting on close dates the buyer controls produces misses every quarter.
Compliance is cost of revenue.
Security and privacy obligations, audits and certifications, business associate agreements, and the infrastructure to support them scale with customers and belong in gross margin.
Multi-year contracts create deferred revenue and collection timing questions.
Annual up-front billing, multi-year discounts, and auto-renewal terms shape cash, revenue recognition, and renewal risk differently than monthly billing.
Customer concentration is common.
A few large health systems or groups can represent a third of revenue; churn of one changes the year and the valuation.
Net revenue retention depends on seats, sites, and modules.
Expansion is driven by provider count, location count, and add-on modules — each needs its own tracking to explain retention.
Interoperability and integration costs are underestimated.
Interfaces to electronic health records, clearinghouses, and labs are built per customer and rarely priced or capitalized correctly.
How we run finance here.
- Revenue recognition that separates implementation, subscription, usage, and professional services; deferred revenue reconciled monthly.
- ARR waterfall — new, expansion, contraction, churn — by customer, with seats, sites, and modules as drivers.
- Pipeline-weighted forecasting calibrated to healthcare sales-cycle history, not close dates.
- Gross margin with compliance, hosting, support, and integration cost properly classified; margin by product and by customer segment.
- Customer concentration and renewal calendar with revenue at risk by quarter.
- Investor and board reporting — ARR, net revenue retention (NRR), gross and net churn, customer acquisition cost (CAC) payback, burn and runway, cohort curves.
- Pricing and packaging analysis — per-provider, per-site, per-module, and usage models against win rates and margin.
- Diligence readiness for the next round or a strategic acquirer: metric definitions, contract review, data room.
Key metrics we build and report.
| Metric | What it tells you |
|---|---|
| ARR by product, segment, and customer | Recurring revenue composition |
| Net revenue retention and gross retention | Expansion vs. churn |
| Implementation revenue and margin, separated | Services economics |
| Gross margin with compliance and hosting in cost of revenue | True product margin |
| Sales cycle length by segment and win rate | Forecast calibration |
| CAC payback and lifetime value (LTV) to CAC by channel | Growth efficiency |
| Customer concentration (top 10) | Revenue risk |
| Deferred revenue and billings | Cash vs. revenue |
| Integration cost per customer | Hidden delivery cost |
| Burn, runway, rule of 40 | Investor view |
Worked example.
A practice-management and billing platform, $11.4M ARR, 220 customers, venture-backed.
The plan: restate ARR and gross margin ahead of the raise; segment-specific pipeline weighting; renewal program for the two large Q2 accounts; module-expansion playbook tracked in the waterfall; pricing review for the health-system tier.
Where we’ve done this.
Practice-management, revenue-cycle, and patient-engagement software companies from seed through growth rounds; provider organizations that were the buyers of such software; sponsor-backed healthcare technology platforms. Pattern-level only.
Why restate gross margin?
Investors and acquirers price healthcare SaaS on recurring margin; if compliance, hosting, and integration cost sit in operating expense, the margin being priced is wrong and diligence will find it.
How do you forecast with such long sales cycles?
Stage-weighted pipeline calibrated to the company's own cycle history by segment, reviewed monthly against actual conversion.
Can you help with pricing for health systems?
Yes — per-provider, per-site, and enterprise models evaluated on win rate, margin, and expansion potential.
Do you work with companies selling to payers?
Yes; the sales cycle and contract structures differ, and we model them separately.
Further reading.
Preparing a Behavioral Health Group for a Sale or Private Equity Investment
What buyers and investors examine in a behavioral health practice — quality of earnings, clinician retention, compliance, and receivables — and how to prepare 12 to 24 months ahead.
Read article → InsightThe Monthly Management Report for a Behavioral Health Group: What Belongs In It
The metrics, statements, and commentary a behavioral health practice's monthly report should contain, with a sample page-one — and the order that makes it useful to owners and boards.
Read article → InsightCost Per New Client: Measuring Intake and Marketing Like a Business
How behavioral health practices should calculate cost to acquire a new client, client lifetime value, and payback — by referral channel and payer — with a worked channel comparison.
Read article →Insights for this vertical.
SaaS-specific insights are being published.
Tell us about the company.
One conversation about where the numbers stand and what the next stage needs from finance. We will tell you where we can help, where you need someone else, and what it would cost.
The information on this page is provided for general informational purposes and does not constitute accounting, tax, legal, or investment advice. Revenue recognition, sales tax, and investor reporting matters for software companies depend on contract terms, jurisdiction, and the specific facts of the business. Figures in examples are illustrative. See our full Legal Disclaimer.